Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

BIOPHYTIS S.A.

(ALBPS)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur BIOPHYTIS S.A.
2021BIOPHYTIS S A : announces the drawing of the last tranche of ORNANE under the 2020 Atlas C..
2021Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Con..
2021BIOPHYTIS S A : to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia f..
2021Biophytis SA to Meet with FDA to Advance Sarconeos Development in Sarcopenia from Phase..
2021Biophytis to Meet with FDA to Advance Sarconeos Development Program
2021Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from..
2021BIOPHYTIS S A : obtains a new 10M€ loan structure with Kreos Capital - Form 6-K
2021Biophytis Obtains A New ?10 Million Loan Structure with Kreos Capital
2021GLOBAL MARKETS LIVE : Samsung, Clariant, AstraZeneca, Amazon, Merck...
2021Biophytis obtains a new 10M? loan structure with Kreos Capital
2021Biophytis SA announced that it expects to receive ?10 million in funding from Kreos Cap..
2021BIOPHYTIS S A : announces US centers to restart recruitment for the COVA phase 2-3 study w..
2021Biophytis SA Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study w..
2021Biophytis Shares Rise 16% Premarket After Restarting Recruitment for Covid-19 Treatment
2021Biophytis Restarts Patient Enrollment in the US for Phase 2/3 Study of Sarconeos in COV..
2021Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with..
2021Biophytis to Report Restated Financial Statements for Previous Periods and as of June 3..
2021Statement by the person responsible for the half-year financial report - Form 6-K
2021BIOPHYTIS S A : To Restate Financial Statements Over Incorrect Accounting
2021BIOPHYTIS S A : to Restate Previously Issued Financial Statements (Form 6-K)
2021BIOPHYTIS S A : to Restate Previously Issued Financial Statements
2021Biophytis to Restate Previously Issued Financial Statements
2021BIOPHYTIS S A : to host virtual KOL event on Sarconeos (BIO101) on its lead projects in CO..
2021BIOPHYTIS S A : announces the drawing of 2 new tranches of ORNANE under the 2020 Atlas Con..
2021BIOPHYTIS S A : to Host Virtual KOL Event on Sarconeos (BIO101) on its Lead Projects in CO..
2021BIOPHYTIS S A : Issues $7 Million Bonds Under 2020 Atlas Deal
2021BIOPHYTIS S A : Announces the Drawing of 2 New Tranches of ORNANE Under the 2020 Atlas Con..
2021BIOPHYTIS S A : announces promising full results from the SARA-INT Phase 2b trial of Sarco..
2021BIOPHYTIS S A : Announces Promising Full Results From the SARA-INT Phase 2b Trial of Sarco..
2021Biophytis Announces Promising Full Results From the SARA-INT Phase 2b Trial of Sarconeo..
2021BIOPHYTIS S A : Exhibi 99.1 (Form 6-K)
2021GLOBAL MARKETS LIVE : Sanofi, ASML, Apple, United Airlines, Netflix...
2021BIOPHYTIS S A : to Present Full Results From the SARA-INT Phase 2b Trial of Sarconeos (BIO..
2021Biophytis to Present Full Results From the SARA-INT Phase 2b Trial of Sarconeos (BIO101..
2021Biophytis to Present Full Results from the Sara-INT Phase 2B Trial of Sarconeos in Sarc..
2021BIOPHYTIS SA(ENXTPA : ALBPS) added to S&P Global BMI Index
2021BIOPHYTIS S A : reports H1 2021 financial results and provides business update (Form 6-K)
2021Biophytis Reports H1 2021 Financial Results and Provides Business Update
2021BIOPHYTIS S A : announces DMC second interim analysis efficacy results in the promising zo..
2021GLOBAL MARKETS LIVE : Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...
2021BIOPHYTIS : Says Data Monitoring Committee Recommends Continuation of COVID-19 Drug Study ..
2021Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone ..
2021Biophytis SA Announces DMC Second Interim Analysis Efficacy Results in the Promising Zo..
2021BIOPHYTIS : to Attend Key Upcoming Investor Events and Industry Conferences
2021BIOPHYTIS : Names New Chief Medical Officer
2021BIOPHYTIS S A : Appoints New Chief Medical Officer
2021Biophytis Leadership is Reinforced With New Chief Medical Officer Appointment
2021Biophytis SA Appoints Rob van Maanen MD MBA as Chief Medical Officer, Member of the Exe..
2021BIOPHYTIS S A : Receives Favorable Recommendation From Data Monitoring Committee (DMC) Bas..
2021BIOPHYTIS S A : Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved..
2021BIOPHYTIS : Says Independent Data Panel Recommends to Continue Patient Recruitment in Stud..
2021BIOPHYTIS S A : COVID-19 Drug Trial Gets Recommendation To Continue Patient Recruitment
2021BIOPHYTIS : Receives Favorable Recommendation From Data Monitoring Committee (DMC) Based o..
2021Biophytis SA Receives Favorable Recommendation from Data Monitoring Committee Based on ..
2021BIOPHYTIS S A : Issues 5 Million New Shares To Negma After Paris Court Ruling
2021BIOPHYTIS : Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for..
2021SECTOR UPDATE : Health Care Stocks Higher Premarket Monday
2021SECTOR UPDATE : Health Care
2021BIOPHYTIS S A : ANNOUNCES TOP LINE RESULTS OF SARA-INT PHASE 2 STUDY WITH SARCONEOS (BIO10..
2021BIOPHYTIS' : Sarconeos Drug Meets Primary Endpoint of Mid-Stage Study in Patients With Sar..
2021Biophytis Announces Top Line Results of SARA-INT Phase 2 Study With Sarconeos (BIO101) ..
2021Biophytis SA Announces Top Line Results of the SARA-INT Phase 2 Clinical Study with Sar..
2021GLOBAL MARKETS LIVE : LVMH, Apple, Microsoft, ABB, SoftwareOne...
2021BIOPHYTIS S A : Judgment rendered on July 16, 2021 in the proceedings between Biophytis an..
2021BIOPHYTIS S A : Judgment rendered on July 16, 2021 in the proceedings between Biophytis an..
2021BIOPHYTIS S A : Appeals Court Ruling in Funding Litigation With Negma
2021BIOPHYTIS S A : Judgment Rendered on July 16, 2021 in the Proceedings Between Biophytis an..
2021BIOPHYTIS : Says Sarconeos Prevented Respiratory Function Deterioration in Animal Model of..
2021Biophytis Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at ECCMI..
2021Biophytis Presents Positive Preclinical Data on Sarconeos in COVID-19 at ECCMID 2021
2021BIOPHYTIS S A : Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at EC..
2021BIOPHYTIS : Names New Chief Medical Officer, Chief Business Officer
2021Biophytis Reinforces Leadership Teams with Three Senior Appointments
2021Biophytis SA Announces Board Changes
2021BIOPHYTIS S A : Reinforces Leadership Teams with Three Senior AppointmentsRead the press r..
1  2  3  4Suiv.
Prochain événement sur BIOPHYTIS S.A.